Humalog 100 units/ml Solution for Injection.
PDF Leaflet Revision Date: 31 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
For treatment of diabetes mellitus requiring insulin.
Dosage (summary)
Individualized; administer shortly before or after meals.
Onset of Action / Duration
Onset: ~15 mins, Duration: 2-5 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Paediatric population
Pregnancy & Breastfeeding
Generally safe; monitor insulin needs during pregnancy and breastfeeding.
Key Drug Interactions
- Hyperglycaemic agents (e.g., corticosteroids)
- Hypoglycaemic agents (e.g., sulphonylureas)
Contraindications
- Hypersensitivity to insulin lispro
- Hypoglycaemia
Common side effects
- Hypoglycaemia
- Local allergy
- Lipodystrophy
Counselling Points
- Educate on proper injection techniques.
- Rotate injection sites to prevent lipodystrophy.
- Monitor blood glucose levels regularly.
Serious warnings
- Risk of severe hypoglycaemia
- Cardiac failure with pioglitazone
Important Disclaimer
The Humalog 100 units/ml Solution for Injection. professional information leaflet below is the property of Eli Lilly (SA) and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
